Literature DB >> 19698808

Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings.

Robin Biellik1, Carol Levin, Emmanuel Mugisha, D Scott LaMontagne, Allison Bingham, Satish Kaipilyawar, Sanjay Gandhi.   

Abstract

This descriptive qualitative study synthesizes health system and immunization financing assessments performed through formative research in India, Peru, Uganda, and Vietnam using a non-probability sample of national and sub-national stakeholders; and recommends appropriate and effective strategies for HPV vaccine delivery in low-resource settings. We conclude that maximum feasibility and acceptability and lowest cost for delivering HPV vaccine can be achieved by implementing through national immunization programs; by partnering with other sectors, such as education and maternal-child health; by strengthening existing human resources and cold chain infrastructures where needed; and finally, by considering schools for reaching the target population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19698808     DOI: 10.1016/j.vaccine.2009.08.003

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon.

Authors:  Richard G Wamai; Claudine Akono Ayissi; Geofrey O Oduwo; Stacey Perlman; Edith Welty; Simon Manga; Javier Gordon Ogembo
Journal:  J Community Health       Date:  2012-10

2.  Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.

Authors:  Emmanuel Mugisha; D Scott LaMontagne; Anne R Katahoire; Daniel Murokora; Edward Kumakech; Rachel Seruyange; Vivien Davis Tsu
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

Review 3.  Anal Squamous Intraepithelial Lesions and Anal Cancer Management in Low Resource Settings.

Authors:  Alexander T Hawkins; Sandy H Fang
Journal:  Clin Colon Rectal Surg       Date:  2022-09-13

4.  The use of cost-effectiveness analysis for pediatric immunization in developing countries.

Authors:  Cindy Low Gauvreau; Wendy J Ungar; Jillian Clare Köhler; Stanley Zlotkin
Journal:  Milbank Q       Date:  2012-12       Impact factor: 4.911

5.  Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam.

Authors:  Carol E Levin; Hoang Van Minh; John Odaga; Swampa Sarit Rout; Diep Nguyen Thi Ngoc; Lysander Menezes; Maria Ana Mendoza Araujo; D Scott LaMontagne
Journal:  Bull World Health Organ       Date:  2013-06-19       Impact factor: 9.408

6.  Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.

Authors:  Wilm Quentin; Fern Terris-Prestholt; John Changalucha; Selephina Soteli; W John Edmunds; Raymond Hutubessy; David A Ross; Saidi Kapiga; Richard Hayes; Deborah Watson-Jones
Journal:  BMC Med       Date:  2012-11-13       Impact factor: 8.775

7.  Assessment of eight HPV vaccination programs implemented in lowest income countries.

Authors:  Joël Ladner; Marie-Hélène Besson; Rachel Hampshire; Lisa Tapert; Mike Chirenje; Joseph Saba
Journal:  BMC Public Health       Date:  2012-05-23       Impact factor: 3.295

8.  Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control.

Authors:  Hextan Y S Ngan; Suzanne M Garland; Neerja Bhatla; Sonia R Pagliusi; Karen K L Chan; Annie N Y Cheung; Tang-Yuan Chu; Efren J Domingo; You Lin Qiao; Jong Sup Park; Eng Hseon Tay; Wisit Supakarapongkul
Journal:  J Cancer Epidemiol       Date:  2011-04-13

9.  Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.

Authors:  Alan Brooks; Olivier J T Briët; Diggory Hardy; Richard Steketee; Thomas A Smith
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 10.  Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects.

Authors:  Jannah Wigle; Ernestina Coast; Deborah Watson-Jones
Journal:  Vaccine       Date:  2013-06-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.